Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: A multi-model study (Q150164)
From geokb
a Article (Journal Article) published by Elsevier as part of series - The Lancet Regional Health - Americas
Language | Label | Description | Also known as |
---|---|---|---|
English | Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021–March 2022: A multi-model study |
a Article (Journal Article) published by Elsevier as part of series - The Lancet Regional Health - Americas |
Statements
1 reference